Handelen Viatris Inc. - VTRS CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Spread | 0.07 | ||||||||
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.025457% | ||||||||
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | 0.003235% | ||||||||
Tijd van overnight-tarief | 21:00 (UTC) | ||||||||
Min. verhandelde hoeveelheid | 1 | ||||||||
Valuta | USD | ||||||||
Marge | 20% | ||||||||
Effectenbeurs | United States of America | ||||||||
Handelscommissie | 0% |
*Information provided by Capital.com
Viatris Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 9 |
Open* | 9.01 |
1-Jaarlijkse Verandering* | -23.71% |
Dagelijks bereik* | 9.01 - 9.1 |
52 wekelijks bereik | 8.42-12.40 |
Weekgemiddelde volume (10 dagen) | 8.57M |
Gemiddeld volume (3 maanden) | 204.84M |
Marktkapitalisatie | 10.92B |
P/E Ratio | 5.83 |
Uitstaande Aandelen | 1.20B |
Omzet | 15.80B |
EPS | 1.56 |
Dividend (opbrengst %) | 5.26894 |
Beta | 1.18 |
Volgende inkomsten datum | Aug 7, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
---|---|---|---|---|---|---|
May 26, 2023 | 9.07 | 0.03 | 0.33% | 9.04 | 9.14 | 8.99 |
May 25, 2023 | 9.00 | 0.12 | 1.35% | 8.88 | 9.02 | 8.81 |
May 24, 2023 | 8.99 | -0.14 | -1.53% | 9.13 | 9.16 | 8.91 |
May 23, 2023 | 9.21 | -0.14 | -1.50% | 9.35 | 9.39 | 9.19 |
May 22, 2023 | 9.43 | 0.03 | 0.32% | 9.40 | 9.63 | 9.40 |
May 19, 2023 | 9.30 | -0.09 | -0.96% | 9.39 | 9.53 | 9.26 |
May 18, 2023 | 9.32 | 0.06 | 0.65% | 9.26 | 9.36 | 9.20 |
May 17, 2023 | 9.26 | 0.09 | 0.98% | 9.17 | 9.32 | 9.09 |
May 16, 2023 | 9.11 | -0.13 | -1.41% | 9.24 | 9.27 | 9.11 |
May 15, 2023 | 9.34 | 0.05 | 0.54% | 9.29 | 9.39 | 9.24 |
May 12, 2023 | 9.26 | -0.07 | -0.75% | 9.33 | 9.36 | 9.22 |
May 11, 2023 | 9.32 | -0.20 | -2.10% | 9.52 | 9.53 | 9.23 |
May 10, 2023 | 9.57 | -0.19 | -1.95% | 9.76 | 9.78 | 9.23 |
May 9, 2023 | 9.72 | 0.01 | 0.10% | 9.71 | 9.81 | 9.59 |
May 8, 2023 | 9.79 | 0.21 | 2.19% | 9.58 | 10.05 | 9.33 |
May 5, 2023 | 9.24 | 0.09 | 0.98% | 9.15 | 9.26 | 9.07 |
May 4, 2023 | 8.98 | -0.08 | -0.88% | 9.06 | 9.10 | 8.92 |
May 3, 2023 | 9.11 | -0.03 | -0.33% | 9.14 | 9.21 | 9.07 |
May 2, 2023 | 9.08 | -0.19 | -2.05% | 9.27 | 9.32 | 8.90 |
May 1, 2023 | 9.32 | 0.04 | 0.43% | 9.28 | 9.36 | 9.28 |
Viatris Inc. Events
Tijd (UTC) (UTC) | Land | Evenement |
---|---|---|
Tuesday, June 13, 2023 | ||
Tijd (UTC) (UTC) 20:20 | Land US
| Evenement Viatris Inc at Goldman Sachs Healthcare Conference Viatris Inc at Goldman Sachs Healthcare ConferenceForecast -Previous - |
Monday, August 7, 2023 | ||
Tijd (UTC) (UTC) 12:30 | Land US
| Evenement Q2 2023 Viatris Inc Earnings Release Q2 2023 Viatris Inc Earnings ReleaseForecast -Previous - |
Monday, November 6, 2023 | ||
Tijd (UTC) (UTC) 13:30 | Land US
| Evenement Q3 2023 Viatris Inc Earnings Release Q3 2023 Viatris Inc Earnings ReleaseForecast -Previous - |
- Jaarlijks
- Per kwartaal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Totale inkomsten | 16262.7 | 17886.3 | 11946 | 11500.5 | 11433.9 |
Inkomsten | 16262.7 | 17886.3 | 11946 | 11500.5 | 11433.9 |
Kosten van opbrengsten, totaal | 9230.2 | 11326.4 | 7404.2 | 6948.6 | 6861.9 |
Brutowinst | 7032.5 | 6559.9 | 4541.8 | 4551.9 | 4572 |
Totale bedrijfskosten | 14651.6 | 17928.3 | 12173.6 | 10795.7 | 10553.7 |
Verkoop/Algemeen/Admin. Uitgaven, Totaal | 3605.9 | 3893.6 | 2571.4 | 2416.9 | 2274.3 |
Onderzoek & Ontwikkeling | 659.8 | 654.6 | 507.5 | 518.8 | 568.7 |
Ongebruikelijke uitgaven (inkomsten) | 1155.7 | 2053.7 | 1690.5 | 911.4 | 848.8 |
Bedrijfsresultaat | 1611.1 | -42 | -227.6 | 704.8 | 880.2 |
Renteopbrengsten (-uitgaven), netto Niet-operationeel | -592.4 | -700.2 | -548.4 | -587.3 | -566.2 |
Overige, Netto | 1794.5 | 77.8 | 54.8 | 36.9 | -15.6 |
Netto inkomen voor belastingen | 2813.2 | -664.4 | -721.2 | 154.4 | 298.4 |
Netto inkomen na belastingen | 2078.6 | -1269.1 | -669.9 | 16.8 | 338 |
Minderheidsbelang | |||||
Netto inkomen voor extra. Posten | 2078.6 | -1269.1 | -669.9 | 16.8 | 338 |
Netto inkomen | 2078.6 | -1269.1 | -669.9 | 16.8 | 352.5 |
Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 2078.6 | -1269.1 | -669.9 | 16.8 | 338 |
Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 2078.6 | -1269.1 | -669.9 | 16.8 | 352.5 |
Verwaterd Netto Inkomen | 2078.6 | -1269.1 | -669.9 | 16.8 | 352.5 |
Verwaterd Gewogen Gemiddelde Aandelen | 1217.4 | 1208.8 | 601.2 | 516.5 | 516.5 |
Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 1.70741 | -1.04988 | -1.11427 | 0.03253 | 0.6544 |
Verwaterde Genormaliseerde Winst per Aandeel | 2.41664 | 0.05444 | 0.71345 | 1.1795 | 1.72259 |
Totale buitengewone posten | 14.5 | ||||
Dividends per Share - Common Stock Primary Issue | 0.48 | 0.33 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Totale inkomsten | 3729.1 | 3876 | 4078.2 | 4116.8 | 4191.7 |
Inkomsten | 3729.1 | 3876 | 4078.2 | 4116.8 | 4191.7 |
Kosten van opbrengsten, totaal | 2100.2 | 2285.9 | 2236 | 2350.5 | 2357.4 |
Brutowinst | 1628.9 | 1590.1 | 1842.2 | 1766.3 | 1834.3 |
Totale bedrijfskosten | 3351.1 | 4072.9 | 3524.4 | 3568.5 | 3485.8 |
Verkoop/Algemeen/Admin. Uitgaven, Totaal | 884.7 | 1056.4 | 891.8 | 838.2 | 819.5 |
Onderzoek & Ontwikkeling | 180.9 | 180.9 | 174.9 | 162 | 142 |
Ongebruikelijke uitgaven (inkomsten) | 185.3 | 549.7 | 221.7 | 217.8 | 166.9 |
Bedrijfsresultaat | 378 | -196.9 | 553.8 | 548.3 | 705.9 |
Renteopbrengsten (-uitgaven), netto Niet-operationeel | -147 | -147.1 | -153.2 | -145.8 | -146.3 |
Overige, Netto | 91.7 | 1812.9 | 26.9 | -13.2 | -32.1 |
Netto inkomen voor belastingen | 322.7 | 1468.9 | 427.5 | 389.3 | 527.5 |
Netto inkomen na belastingen | 224.7 | 1011.2 | 354.3 | 313.9 | 399.2 |
Netto inkomen voor extra. Posten | 224.7 | 1011.2 | 354.3 | 313.9 | 399.2 |
Netto inkomen | 224.7 | 1011.2 | 354.3 | 313.9 | 399.2 |
Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 224.7 | 1011.2 | 354.3 | 313.9 | 399.2 |
Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 224.7 | 1011.2 | 354.3 | 313.9 | 399.2 |
Verwaterd Netto Inkomen | 224.7 | 1011.2 | 354.3 | 313.9 | 399.2 |
Verwaterd Gewogen Gemiddelde Aandelen | 1205.6 | 1221.3 | 1218.1 | 1217.1 | 1213.1 |
Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 0.18638 | 0.82797 | 0.29086 | 0.25791 | 0.32907 |
Dividends per Share - Common Stock Primary Issue | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 |
Verwaterde Genormaliseerde Winst per Aandeel | 0.2934 | 1.1471 | 0.4417 | 0.4022 | 0.43319 |
- Jaarlijks
- Per kwartaal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Totaal vlottende activa | 10635.4 | 10902.9 | 12867.5 | 6757.3 | 6367.7 |
Geldmiddelen en kortetermijnbeleggingen | 1337.8 | 790.4 | 929.3 | 541.4 | 445.6 |
Geldmiddelen & Equivalenten | 1259.9 | 701.2 | 844.4 | 475.6 | 388.1 |
Korte Termijn Investeringen | 77.9 | 89.2 | 84.9 | 65.8 | 57.5 |
Totale Vorderingen, Netto | 3814.5 | 4266.4 | 4843.8 | 3058.8 | 2881 |
Accounts Receivable - Trade, Net | 3243.8 | 3774.4 | 3891.3 | 2640.1 | 2416.5 |
Total Inventory | 3519.5 | 3977.7 | 5471.9 | 2670.9 | 2580.2 |
Prepaid Expenses | 194.6 | 256.7 | 267.8 | 156.7 | 130.6 |
Other Current Assets, Total | 1769 | 1611.7 | 1354.7 | 329.5 | 330.3 |
Total Assets | 50022.2 | 54842.8 | 61553 | 31255.5 | 32734.9 |
Property/Plant/Equipment, Total - Net | 3283.8 | 3479.4 | 3783.5 | 2404.2 | 2170.2 |
Property/Plant/Equipment, Total - Gross | 5343.1 | 5879.9 | 6045.5 | 4377.5 | 3974.5 |
Accumulated Depreciation, Total | -2059.3 | -2400.5 | -2262 | -1973.3 | -1804.3 |
Goodwill, Net | 10425.8 | 12113.7 | 12347 | 9590.6 | 9747.8 |
Intangibles, Net | 22607.1 | 26134.2 | 29683.2 | 11649.9 | 13664.6 |
Long Term Investments | 94 | 0 | 47.9 | 92.2 | 138.7 |
Other Long Term Assets, Total | 2976.1 | 2212.6 | 2823.9 | 761.3 | 645.9 |
Total Current Liabilities | 6746.2 | 9884.4 | 10562.9 | 5569.1 | 4587.8 |
Accounts Payable | 1158 | 1056.1 | 1345.7 | 1528.1 | 1617 |
Accrued Expenses | 2188.9 | 3226.4 | 2735.9 | 1563.6 | 1279.2 |
Notes Payable/Short Term Debt | 0 | 1493 | 1100.9 | 0 | 1.9 |
Current Port. of LT Debt/Capital Leases | 1250.5 | 1860.3 | 2256.3 | 1457.6 | 655.2 |
Other Current Liabilities, Total | 2148.8 | 2248.6 | 3124.1 | 1019.8 | 1034.5 |
Total Liabilities | 28949.9 | 34350.1 | 38598.9 | 19371.7 | 20567.8 |
Total Long Term Debt | 18015.2 | 19717.1 | 22429.2 | 11214.3 | 13161.2 |
Long Term Debt | 18015.2 | 19717.1 | 22429.2 | 11214.3 | 13161.2 |
Deferred Income Tax | 2432 | 2815 | 3123.7 | 1627.5 | 1722 |
Minority Interest | |||||
Other Liabilities, Total | 1756.5 | 1933.6 | 2483.1 | 960.8 | 1096.8 |
Total Equity | 21072.3 | 20492.7 | 22954.1 | 11883.8 | 12167.1 |
Common Stock | 12.1 | 12.1 | 12.1 | 6.1 | 6 |
Additional Paid-In Capital | 18645.8 | 18536.1 | 18438.8 | 8643.5 | 8591.4 |
Retained Earnings (Accumulated Deficit) | 5175.6 | 3688.8 | 5361.2 | 6031.1 | 6010.7 |
Treasury Stock - Common | 0 | -999.7 | -999.7 | ||
Unrealized Gain (Loss) | -2.3 | 0 | 1.2 | 0.6 | 0 |
Other Equity, Total | -2758.9 | -1744.3 | -859.2 | -1797.8 | -1441.3 |
Total Liabilities & Shareholders’ Equity | 50022.2 | 54842.8 | 61553 | 31255.5 | 32734.9 |
Total Common Shares Outstanding | 1213.79 | 1209.51 | 1206.9 | 516.149 | 515.799 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Totaal vlottende activa | 9630.3 | 10635.4 | 10487.8 | 11176.5 | 11744.3 |
Geldmiddelen en kortetermijnbeleggingen | 587.6 | 1337.8 | 721 | 741.9 | 837 |
Geldmiddelen & Equivalenten | 506.6 | 1259.9 | 646.7 | 664.7 | 752.4 |
Korte Termijn Investeringen | 81 | 77.9 | 74.3 | 77.2 | 84.6 |
Totale Vorderingen, Netto | 3497.5 | 3814.5 | 3333.9 | 3736.2 | 4093.9 |
Accounts Receivable - Trade, Net | 3021.9 | 3243.8 | 2829.8 | 3182.9 | 3556.9 |
Total Inventory | 3664.3 | 3519.5 | 3380.4 | 3612.5 | 3797.3 |
Prepaid Expenses | 239.7 | 194.6 | 237.1 | 274 | 268.1 |
Other Current Assets, Total | 1641.2 | 1769 | 2815.4 | 2811.9 | 2748 |
Total Assets | 49290.2 | 50022.2 | 48662.6 | 51125.1 | 53466.9 |
Property/Plant/Equipment, Total - Net | 3261.6 | 3283.8 | 3303.2 | 3359 | 3431.9 |
Property/Plant/Equipment, Total - Gross | 5398.9 | 5343.1 | 5282.8 | 5316.5 | 5374.2 |
Accumulated Depreciation, Total | -2137.3 | -2059.3 | -1979.6 | -1957.5 | -1942.3 |
Goodwill, Net | 10573.2 | 10425.8 | 10054.6 | 10523 | 10978.8 |
Intangibles, Net | 22701.6 | 22607.1 | 23013.3 | 24101.1 | 25251.8 |
Long Term Investments | 94 | ||||
Other Long Term Assets, Total | 3123.5 | 2976.1 | 1803.7 | 1965.5 | 2060.1 |
Total Current Liabilities | 6108.1 | 6746.2 | 6521.4 | 7681.2 | 9642.9 |
Accounts Payable | 1415.4 | 1158 | 791.2 | 1050.7 | 928.4 |
Accrued Expenses | 2130.1 | 2188.9 | 2271 | 2427.4 | 2848.3 |
Notes Payable/Short Term Debt | 204.6 | 0 | 500.4 | 1019.7 | 655.4 |
Current Port. of LT Debt/Capital Leases | 500.1 | 1250.5 | 755 | 758.6 | 2595.4 |
Other Current Liabilities, Total | 1857.9 | 2148.8 | 2203.8 | 2424.8 | 2615.4 |
Total Liabilities | 28362.3 | 28949.9 | 29480.3 | 31319.7 | 33019.2 |
Total Long Term Debt | 18069.4 | 18015.2 | 18724.5 | 19206.4 | 18762.5 |
Long Term Debt | 18069.4 | 18015.2 | 18724.5 | 19206.4 | 18762.5 |
Deferred Income Tax | 2465 | 2432 | 2489.3 | 2617.9 | 2729.5 |
Other Liabilities, Total | 1719.8 | 1756.5 | 1745.1 | 1814.2 | 1884.3 |
Total Equity | 20927.9 | 21072.3 | 19182.3 | 19805.4 | 20447.7 |
Common Stock | 12.2 | 12.1 | 12.1 | 12.1 | 12.1 |
Additional Paid-In Capital | 18679.6 | 18645.8 | 18616.8 | 18585.7 | 18555.1 |
Retained Earnings (Accumulated Deficit) | 5252.5 | 5175.6 | 4312.5 | 4106.8 | 3941.5 |
Unrealized Gain (Loss) | -1.6 | -2.3 | -2.7 | -2.1 | -1.3 |
Other Equity, Total | -2763 | -2758.9 | -3756.4 | -2897.1 | -2059.7 |
Total Liabilities & Shareholders’ Equity | 49290.2 | 50022.2 | 48662.6 | 51125.1 | 53466.9 |
Total Common Shares Outstanding | 1198.98 | 1213.79 | 1212.65 | 1212.45 | 1212.32 |
Treasury Stock - Common | -251.8 |
- Jaarlijks
- Per kwartaal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Netto-inkomen/Beginsaldo | 2078.6 | -1269.1 | -669.9 | 16.8 | 352.5 |
Geldmiddelen uit Operationele Activiteiten | 2952.6 | 3016.9 | 1231.8 | 1803.7 | 2341.7 |
Geldmiddelen uit Operationele Activiteiten | 3027.6 | 4506.5 | 2216.1 | 2019.3 | 2109.9 |
Deferred Taxes | -25.9 | 675.7 | -213.2 | -192.6 | -264.3 |
Niet-Geldelijke Posten | -1205.1 | 908.6 | 595.1 | 468 | 332.6 |
Cash Taxes Paid | 735.2 | 641.7 | 324.4 | 278.6 | 228.6 |
Contant Betaalde Rente | 642.5 | 684.8 | 555.4 | 470.6 | 460.8 |
Veranderingen in het Operationeel Kapitaal | -922.6 | -1804.8 | -696.3 | -507.8 | -189 |
Geldmiddelen uit Investeringsactiviteiten | 1520.5 | -117.8 | -301.1 | -525.4 | -1210.4 |
Kapitaaluitgaven | -443 | -509.4 | -681.2 | -406 | -1195.6 |
Overige Cash Flow investeringsposten, Totaal | 1963.5 | 391.6 | 380.1 | -119.4 | -14.8 |
Geldmiddelen uit Financieringsactiviteiten | -3877.9 | -3012 | -605.7 | -1169 | -1090.9 |
Financiering van Cash Flow Posten | -19.5 | -513.9 | -205 | -74.2 | -45 |
Uitgifte (Aflossing) van aandelen, netto | 3.3 | 0 | 0.6 | 8.1 | -414.2 |
Uitgifte (Aflossing) van Schulden, Netto | -3280.1 | -2099.1 | -401.3 | -1102.9 | -631.7 |
Wisselkoerseffecten | -38.9 | -30.9 | 33.8 | -7.5 | -21 |
Nettowijziging in Geldmiddelen | 556.3 | -143.8 | 358.8 | 101.8 | 19.4 |
Total Cash Dividends Paid | -581.6 | -399 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 224.7 | 2078.6 | 1067.4 | 713.1 | 399.2 |
Cash From Operating Activities | 971.2 | 2952.6 | 2810 | 1941 | 1138.5 |
Cash From Operating Activities | 730 | 3027.6 | 2157.8 | 1458.3 | 736 |
Deferred Taxes | -26.7 | -25.9 | -179.5 | -157.6 | -52.8 |
Non-Cash Items | 74.6 | -1205.1 | 285.7 | 71.5 | 71.2 |
Changes in Working Capital | -31.4 | -922.6 | -521.4 | -144.3 | -15.1 |
Cash From Investing Activities | -749.5 | 1520.5 | -264 | -149 | -66.9 |
Capital Expenditures | -82.5 | -443 | -277.1 | -161.4 | -71.9 |
Other Investing Cash Flow Items, Total | -667 | 1963.5 | 13.1 | 12.4 | 5 |
Cash From Financing Activities | -974.7 | -3877.9 | -2547.3 | -1788.6 | -1009 |
Financing Cash Flow Items | -36.3 | -19.5 | -34.5 | -33.6 | -26 |
Issuance (Retirement) of Stock, Net | -249.1 | 3.3 | 2.5 | 0.7 | |
Issuance (Retirement) of Debt, Net | -545.5 | -3280.1 | -2079.2 | -1465.1 | -837.9 |
Foreign Exchange Effects | 1.2 | -38.9 | -54.5 | -40.2 | -11.4 |
Net Change in Cash | -751.8 | 556.3 | -55.8 | -36.8 | 51.2 |
Total Cash Dividends Paid | -143.8 | -581.6 | -436.1 | -290.6 | -145.1 |
Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 12.1166 | 145282251 | -3467515 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.0169 | 60154001 | -1473667 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.9855 | 59777858 | -2118712 | 2023-03-31 | LOW |
Davis Selected Advisers, L.P. | Investment Advisor/Hedge Fund | 4.5878 | 55009008 | 287401 | 2023-03-31 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 3.261 | 39100391 | 8620870 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 2.2029 | 26413851 | 327226 | 2023-03-31 | LOW |
Camber Capital Management LP | Hedge Fund | 1.8765 | 22500000 | 2500000 | 2023-03-31 | MED |
Invesco Capital Management LLC | Investment Advisor | 1.5261 | 18297851 | -994629 | 2023-03-31 | LOW |
Laurion Capital Management LP | Hedge Fund | 1.5217 | 18246173 | -1728077 | 2023-03-31 | HIGH |
Deerfield Management Company, L.P. | Hedge Fund | 1.4125 | 16935997 | 6935997 | 2023-03-31 | MED |
Arrowstreet Capital, Limited Partnership | Investment Advisor/Hedge Fund | 1.2217 | 14648441 | -4157981 | 2023-03-31 | MED |
Pacer Advisors, Inc. | Investment Advisor | 1.2109 | 14518713 | 2276353 | 2023-03-31 | HIGH |
Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 0.9737 | 11674652 | -2384730 | 2023-03-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9398 | 11268020 | 3237508 | 2022-12-31 | LOW |
AQR Capital Management, LLC | Investment Advisor/Hedge Fund | 0.9301 | 11151798 | -215703 | 2023-03-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 0.9292 | 11141851 | -6895029 | 2023-03-31 | HIGH |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.9105 | 10916998 | -28594 | 2023-03-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.8801 | 10552667 | 186280 | 2023-03-31 | LOW |
BlackRock Asset Management Ireland Limited | Investment Advisor | 0.8056 | 9659742 | -750065 | 2023-03-31 | LOW |
Federated Hermes Equity Management Company of Pennsylvania | Investment Advisor | 0.7421 | 8897621 | -1041973 | 2023-03-31 | MED |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group530K+
Handelaren
87K+
Actieve klanten per maand
$46M+
Maandelijks beleggingsvolume
$31M+
Opgenomen per maand
Handelscalculator
Bereken uw virtuele winst- en verliesrekening indien u een CFD-positie had geopend op een bepaalde datum (kies een datum) en gesloten op een andere datum (kies een datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Viatris Inc. Company profile
Over Viatris Inc.
Viatris Inc. is een wereldwijd opererend bedrijf in de gezondheidszorg. Het bedrijf heeft vier segmenten: Ontwikkelde markten, Groot-China, JANZ en Opkomende markten. Het segment Ontwikkelde markten omvat haar activiteiten voornamelijk in Noord-Amerika en Europa. Het segment Groter China omvat haar operaties in China, Taiwan en Hong Kong. Het segment JANZ vertegenwoordigt de activiteiten in Japan, Australië en Nieuw-Zeeland. Het segment Opkomende markten omvat haar aanwezigheid in ongeveer 125 landen met zich ontwikkelende markten en opkomende economieën, waaronder in Azië, Afrika, Oost-Europa, Latijns-Amerika en het Midden-Oosten, evenals haar anti-retrovirale franchise. De portefeuille omvat ongeveer 1.400 goedgekeurde moleculen in een reeks belangrijke therapeutische gebieden, waaronder wereldwijd erkende iconische en belangrijke merken, generieke geneesmiddelen, complexe generieke geneesmiddelen en biosimilars. Het bedrijf heeft wereldwijd ongeveer 40 productiesites, waar orale vaste doses, injecteerbare producten, complexe doseringsvormen en actieve farmaceutische ingrediënten worden geproduceerd.
Industry: | Pharmaceuticals (NEC) |
1000 Mylan Boulevard
CANONSBURG
PENNSYLVANIA 15317
US
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 530.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen